Jun 04, 2019 / 02:00PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
Thanks for joining us, everyone. We'll go ahead and get started. Good morning. Welcome to Jefferies 2019 Global Healthcare Conference. I'm Brandon Couillard. I cover Life Science Tools and Diagnostics sector here at Jefferies. Very happy to have Bio-Rad with us back at the conference this year and here to share -- and update with us on the story and the company and all of their progress, CEO, Norman Schwartz. We also have brand-new CFO, Ilan Daskal, with us on here on stage, who will join us downstairs for the breakout afterwards. Norman?
Norman D. Schwartz - Bio-Rad Laboratories, Inc. - Chairman, CEO & President
Okay. Thank you, Brandon. Thank you all for joining us this morning. We're going to take the opportunity this morning to tell you a little bit about Bio-Rad, a little bit about our rich history and how we've contributed to science and health care and where we've been investing and what we see for the future.
Before we get started, I caution you that we will be making
Bio Rad Laboratories Inc at Jefferies Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot